MIRATI THERAPEUTICS INC (MRTX)
US60468T1051 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.4M 301.20% | 72.09M 437.99% | 12.44M -82.74% | 62.951M 406.04% | 182.56M 190.00% | 329.19M 80.32% | 505.03M 53.42% | 736.43M 45.82% | 1.026B 39.32% | 1.435B 39.86% | 1.641B 14.36% | |
| EBITDA YoY % growth | -368.72M -66.20% | -571.4M -54.97% | -756.66M -32.42% | -714.041M 5.63% | -645.051M 9.66% | -517.274M 19.81% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -369.36M -66.30% | -573.18M -55.18% | -759.59M -32.52% | -536.499M 29.37% | -550.043M -2.52% | -729.495M -32.63% | -420.601M 42.34% | -194.204M 53.83% | 87.824M 145.22% | 387.13M 340.80% | 571.17M 47.54% | |
| Operating Margin | -2,756.42% | -795.09% | -6,106.03% | -852.25% | -301.29% | -221.60% | -83.28% | -26.37% | 8.56% | 26.98% | 34.81% | |
| EPS YoY % growth | -7.95 -40.96% | -11.17 -40.50% | -13.18 -17.99% | -11.33 14.07% | -9.31 17.83% | -7.77 16.54% | -5.90 24.06% | -2.09 64.52% | 2.01 195.90% | 5.91 194.28% | 6.89 16.64% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.67 23.91% | -2.59 18.61% | -2.45 19.31% | -2.31 7.11% | -2.05 23.11% |
| Revenue Q2Q % growth | 25.741M 2,667.85% | 23.208M 223.68% | 33.34M 143.54% | 42.996M 162.17% | 61.149M 137.55% |
| EBITDA Q2Q % growth | -183.6M 12.06% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -157.111M 25.79% | -159.414M 17.75% | -157.684M 15.80% | -145.275M 15.56% | -165.701M -5.47% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -2.49 19.42% | -2.90 | 0.41 | 14.01% |
| Q2 2023 Q2Q % growth | -3.04 4.40% | -3.23 | 0.19 | 6.02% |
| Q1 2023 Q2Q % growth | -3.18 6.47% | -3.62 | 0.44 | 12.21% |
| Q4 2022 Q2Q % growth | -3.51 5.65% | -3.62 | 0.11 | 3.16% |
| Q3 2022 Q2Q % growth | -3.09 -99.35% | -3.55 | 0.46 | 12.84% |
| Q2 2022 Q2Q % growth | -3.18 1.55% | -3.56 | 0.38 | 10.56% |
| Q1 2022 Q2Q % growth | -3.40 -27.34% | -3.56 | 0.16 | 4.40% |
| Q4 2021 Q2Q % growth | -3.72 -78.85% | -3.06 | -0.66 | -21.42% |
| Q3 2021 Q2Q % growth | -1.55 20.92% | -2.94 | 1.39 | 47.35% |
| Q2 2021 Q2Q % growth | -3.23 -70.90% | -2.45 | -0.78 | -31.90% |
| Q1 2021 Q2Q % growth | -2.67 -32.18% | -2.18 | -0.49 | -22.64% |
| Q4 2020 Q2Q % growth | -2.08 -13.66% | -2.28 | 0.20 | 8.70% |
| Q3 2020 Q2Q % growth | -1.96 -42.03% | -2.01 | 0.05 | 2.64% |
| Q2 2020 Q2Q % growth | -1.89 -50.00% | -2.13 | 0.24 | 11.41% |
| Q1 2020 Q2Q % growth | -2.02 -72.65% | -1.70 | -0.32 | -19.06% |
| Q4 2019 Q2Q % growth | -1.83 -110.34% | -1.47 | -0.36 | -24.38% |
| Q3 2019 Q2Q % growth | -1.38 -62.35% | -1.28 | -0.10 | -7.63% |
| Q2 2019 Q2Q % growth | -1.26 -34.04% | -1.22 | -0.04 | -3.03% |
| Q1 2019 Q2Q % growth | -1.17 -129.41% | -0.99 | -0.18 | -18.66% |
| Q4 2018 Q2Q % growth | -0.87 | -0.89 | 0.02 | 2.02% |
| Q3 2018 Q2Q % growth | -0.85 | -0.89 | 0.04 | 4.53% |
| Q2 2018 Q2Q % growth | -0.94 | -0.80 | -0.14 | -17.92% |
| Q1 2018 Q2Q % growth | -0.51 | -0.62 | 0.11 | 17.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 16.4M 202.03% | 18.97M | -2.57M | -13.55% |
| Q2 2023 Q2Q % growth | 13.69M 155.41% | 13.78M | -90K | -0.65% |
| Q1 2023 Q2Q % growth | 7.17M 909.86% | 4.874M | 2.296M | 47.11% |
| Q4 2022 Q2Q % growth | 930K 210.00% | 2.318M | -1.388M | -59.88% |
| Q3 2022 Q2Q % growth | 5.43M -92.44% | 1.285M | 4.145M | 322.57% |
| Q2 2022 Q2Q % growth | 5.36M | 351.9K | 5.008M | 1,423.16% |
| Q1 2022 Q2Q % growth | 710K | 159.375K | 550.625K | 345.49% |
| Q4 2021 Q2Q % growth | 300K -82.46% | 2.068M | -1.768M | -85.49% |
| Q3 2021 Q2Q % growth | 71.79M 528.63% | 10.838M | 60.952M | 562.39% |
| Q2 2021 Q2Q % growth | 6.758M | -6.758M | -100.00% | |
| Q1 2021 Q2Q % growth | -100.00% | 141.668K | -141.668K | -100.00% |
| Q4 2020 Q2Q % growth | 1.71M 222.64% | 276.247K | 1.434M | 519.01% |
| Q3 2020 Q2Q % growth | 11.42M 1,053.54% | 2.748M | 8.672M | 315.57% |
| Q2 2020 Q2Q % growth | -100.00% | 785.869K | -785.869K | -100.00% |
| Q1 2020 Q2Q % growth | 270K -78.23% | 270.3K | -300 | -0.11% |
| Q4 2019 Q2Q % growth | 530K -84.68% | 220.238K | 309.762K | 140.65% |
| Q3 2019 Q2Q % growth | 990K | 214.2K | 775.8K | 362.18% |
| Q2 2019 Q2Q % growth | 580K | 156.927K | 423.073K | 269.60% |
| Q1 2019 Q2Q % growth | 1.24M -86.91% | 1.24M | % | |
| Q4 2018 Q2Q % growth | 3.46M | 1.326M | 2.134M | 160.94% |
| Q2 2018 Q2Q % growth | 40.463K | -40.463K | -100.00% | |
| Q1 2018 Q2Q % growth | 9.47M | 3.4M | 6.07M | 178.53% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.83% | 2.99% | 0.29% | 4.82% |
| Revenue | -0.7% | 2.49% | -2.26% | -3.77% |